| Trial ID: | L0752 |
| Source ID: | NCT01537315
|
| Associated Drug: |
Hydroxychloroquine
|
| Title: |
Hydroxychloroquine in Cardiovascular Disease in Patients With Chronic Kidney Disease: A Proof of Concept Study
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01537315/results
|
| Conditions: |
Kidney Failure, Chronic|Cardiovascular Disease|Arteriosclerosis
|
| Interventions: |
DRUG: Hydroxychloroquine|OTHER: Matching Placebo
|
| Outcome Measures: |
Primary: Change From Baseline in Inflammatory Marker, Hs-C Reactive Protein, at 6 Months, Hs-CRP will be measured at baseline (before study drug) and at end of study (6 months). This marker is measured by ELISA assay from serum., Baseline and 6 months |
|
| Sponsor/Collaborators: |
Sponsor: University of Arkansas
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
8
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2012-02
|
| Completion Date: |
2013-09
|
| Results First Posted: |
2014-11-19
|
| Last Update Posted: |
2014-11-19
|
| Locations: |
Central Arkansas Veterans Healthcare System, Little Rock, Arkansas, 72205, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, 72205, United States|University of Florida, Gainesville, Florida, 32610-0224, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01537315
|
